Annual report 2023

A unique network with strong partners.

Key figures

Financial key figures

3,746.0

Net sales
in million CHF

191.3

EBIT adjusted

in million CHF

2.20

Dividend

in CHF per share

Key social figures

7,902

Number of employees as of 31.12.2023

5.4

Investment in employee development in million CHF

98.8%

Availability of medicinal products on average 2023

Key environmental figures

46%

Energy consumption from renewable sources

12.0

Energy intensity in MWh/FTE

41%

Waste is recycled on average 2023

Management report

Galenica Group sales performed well in 2023, growing 4.4% to CHF 3,746.0 million. The adjusted EBIT increased slightly to CHF 191.3 million.

Woman in the camp smiles into the camera
Woman in the camp smiles into the camera
Supplier and pharmacist smile at each other
Supplier and pharmacist smile at each other

Report on non-financial matters pursuant to Art. 964a of the Swiss Code of Obligations

In accordance with the provisions of the Swiss Code of Obligations (CO), we are hereby publishing a report on non-financial matters pursuant to Art. 964a et seq. for the first time for the 2023 financial year.

iPad in the hand
iPad in the hand

Download center

All documents at a glance

Virginie Pache, Chief Pharmacies Officer

«The Group’s bricks-and-mortar pharmacies play a key role in Galenica’s push to integrate and network healthcare in Switzerland.»

Virginie Pache, Chief Pharmacies Officer

Footer